CHELsea: Clinically Assisted Hydration at end of Life. A cluster randomised trial of clinically-assisted hydration for cancer patients in the last days of life (feasibility study)

Study code 
CTU-340
Disease 
Cancer
Recruitment 
Closed
Date 
27/02/2015 to 30/06/2016
Status 
Analysis & Reporting

CHELsea is a palliative care, cluster randomised, feasibility trial on clinically-assisted hydration at the end of life in patients with cancer.

The trial objectives include methodological and ethical issues to be understood and addressed to ensure a future robust, adequately powered, randomised controlled trial is designed to understand the impact of clinically-assisted hydration on survival, anti-psychotic drug use and delerium. The protocol for the CHELsea trial has been published (Trials 2015 16:464) and the full publication can be found at http://www.trialsjournal.com/content/16/1/464 or http://ctu.surrey.ac.uk/ctu-publications

Trim content